The race is on to develop a vaccine for the new coronavirus. It’s a global emergency, which means nearly the entire world population of more than 7 billion is going to need a vaccine. There could be lots of money for the company that comes up with a vaccine, or maybe not. Today, a public-private partnership between American pharmaceutical giant, Merck, and the nonprofit scientific research group IAVI was announced. The World’s host Marco Werman speaks with the president and CEO of IAVI, Mark Feinberg, about how this new arrangement will work.